Last 12 months
Inside the activity.
4 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 09, 2017 Filed May 12, 2017 00:33 UTC |
Hienrich EdiSVP/Managing Director EMEA
|
Tax withholdingCommon Stock | 10,378 | $72.81 | $755,622.18 |
DisclosureSEC source: 0001209191-17-031676 · doc4.xml · nonDerivative · entry 3 Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,119 F3 · kind: The reporting person received 8,631 shares of common stock upon the net exercise of the 24,000 stock appreciation rights ("SARS"). The reporting person forfeited 4,991 shares of common stock underlying the SARS in payment of the exercise price and 10,378 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81. Read SEC document |
| May 09, 2017 Filed May 12, 2017 00:33 UTC |
Hienrich EdiSVP/Managing Director EMEA
|
Disposition to issuerCommon Stock | 4,991 | $72.81 | $363,394.71 |
DisclosureSEC source: 0001209191-17-031676 · doc4.xml · nonDerivative · entry 2 Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,497 F3 · kind: The reporting person received 8,631 shares of common stock upon the net exercise of the 24,000 stock appreciation rights ("SARS"). The reporting person forfeited 4,991 shares of common stock underlying the SARS in payment of the exercise price and 10,378 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81. Read SEC document |
| May 09, 2017 Filed May 12, 2017 00:33 UTC |
Hienrich EdiSVP/Managing Director EMEA
|
Exercise / conversionCommon Stock | 24,000 | $15.14 | $363,360.00 |
DisclosureSEC source: 0001209191-17-031676 · doc4.xml · nonDerivative · entry 1 Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2016. F2 · balance_after: The total number of shares has been adjusted to include 4,628 shares inadvertently omitted from prior reports. Read SEC document |
| May 08, 2017 Filed May 10, 2017 00:30 UTC |
COZZA KEITHDirector
|
GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031111 · doc4.xml · nonDerivative · entry 1 COZZA KEITH · CIK 0001559415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,094 F1 · kind: Consists of restricted stock units under the Herbalife Ltd. 2014 Stock Incentive Plan. This award will vest 100% on April 15, 2018. Read SEC document |
| May 08, 2017 Filed May 10, 2017 00:41 UTC |
Tartol JohnDirector
|
GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031121 · doc4.xml · nonDerivative · entry 1 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,087 F1 · kind: Consists of restricted stock units under the Herbalife Ltd. 2014 Stock Incentive Plan. This award will vest 100% on April 15, 2018. Read SEC document |
| May 08, 2017 Filed May 10, 2017 00:28 UTC |
Cardoso PedroDirector
|
GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031104 · doc4.xml · nonDerivative · entry 1 Cardoso Pedro · CIK 0001463406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,871 F1 · kind: Consists of restricted stock units under the Herbalife Ltd. 2014 Stock Incentive Plan. This award will vest 100% on April 15, 2018. Read SEC document |
| May 08, 2017 Filed May 10, 2017 00:33 UTC |
Otero MariaDirector
|
GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031119 · doc4.xml · nonDerivative · entry 1 Otero Maria · CIK 0001594205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,094 F1 · kind: Consists of restricted stock units under the Herbalife Ltd. 2014 Stock Incentive Plan. This award will vest 100% on April 15, 2018. Read SEC document |
| May 08, 2017 Filed May 10, 2017 00:33 UTC |
Nelson James LarryDirector
|
GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031118 · doc4.xml · nonDerivative · entry 1 Nelson James Larry · CIK 0001424471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,094 F1 · kind: Consists of restricted stock units under the Herbalife Ltd. 2014 Stock Incentive Plan. This award will vest 100% on April 15, 2018. Read SEC document |
| May 08, 2017 Filed May 10, 2017 00:32 UTC |
Montelongo MichaelDirector
|
GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031117 · doc4.xml · nonDerivative · entry 1 Montelongo Michael · CIK 0001328755 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,094 F1 · kind: Consists of restricted stock units under the Herbalife Ltd. 2014 Stock Incentive Plan. This award will vest 100% on April 15, 2018. Read SEC document |
| May 08, 2017 Filed May 10, 2017 00:31 UTC |
GARY HUNTER CLARKDirector
|
GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031114 · doc4.xml · nonDerivative · entry 1 GARY HUNTER CLARK · CIK 0001425798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,094 F1 · kind: Consists of restricted stock units under the Herbalife Ltd. 2014 Stock Incentive Plan. This award will vest 100% on April 15, 2018. Read SEC document |
| May 08, 2017 Filed May 10, 2017 00:31 UTC |
LYNN JESSEDirector
|
GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031115 · doc4.xml · nonDerivative · entry 1 LYNN JESSE · CIK 0001605350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,094 F1 · kind: Consists of restricted stock units under the Herbalife Ltd. 2014 Stock Incentive Plan. This award will vest 100% on April 15, 2018. Read SEC document |
| May 08, 2017 Filed May 10, 2017 00:29 UTC |
CHRISTODORO JONATHANDirector
|
GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031109 · doc4.xml · nonDerivative · entry 1 CHRISTODORO JONATHAN · CIK 0001575440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,094 F1 · kind: Consists of restricted stock units under the Herbalife Ltd. 2014 Stock Incentive Plan. This award will vest 100% on April 15, 2018. Read SEC document |
| May 08, 2017 Filed May 10, 2017 00:29 UTC |
Carmona Richard HDirector
|
GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031107 · doc4.xml · nonDerivative · entry 1 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,094 F1 · kind: Consists of restricted stock units under the Herbalife Ltd. 2014 Stock Incentive Plan. This award will vest 100% on April 15, 2018. Read SEC document |
| May 08, 2017 Filed May 10, 2017 00:28 UTC |
Dunn JeffDirector
|
GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031102 · doc4.xml · nonDerivative · entry 1 Dunn Jeff · CIK 0001476192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,254 F1 · kind: Consists of restricted stock units under the Herbalife Ltd. 2014 Stock Incentive Plan. This award will vest 100% on April 15, 2018. Read SEC document |
| May 08, 2017 Filed May 10, 2017 00:26 UTC |
Bermingham Richard PDirector
|
GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031100 · doc4.xml · nonDerivative · entry 2 Bermingham Richard P · CIK 0001301747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,094 F2 · kind: Consists of restricted stock units under the Herbalife Ltd. 2014 Stock Incentive Plan. This award will vest 100% on April 15, 2018. Read SEC document |
| May 05, 2017 Filed May 10, 2017 00:39 UTC |
Chiu Shin-Shing BoscoPrincipal Accounting Officer
|
Exercise / conversionStock Appreciation Rights · Derivative | 5,000 | $0.00 Strike: $6.82 | $0.00 |
DisclosureSEC source: 0001209191-17-031120 · doc4.xml · derivative · entry 5 Chiu Shin-Shing Bosco · CIK 0001504597 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2019-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2016. Read SEC document |
| May 05, 2017 Filed May 10, 2017 00:39 UTC |
Chiu Shin-Shing BoscoPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 1,695 | $69.40 | $117,633.00 |
DisclosureSEC source: 0001209191-17-031120 · doc4.xml · nonDerivative · entry 3 Chiu Shin-Shing Bosco · CIK 0001504597 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,813 F2 · kind: The reporting person forfeited 492 shares of common stock underlying the SARS in payment of the exercise price and 1,695 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 5, 2017 of $69.40. Read SEC document |
| May 05, 2017 Filed May 10, 2017 00:39 UTC |
Chiu Shin-Shing BoscoPrincipal Accounting Officer
|
Disposition to issuerCommon Stock | 492 | $69.40 | $34,144.80 |
DisclosureSEC source: 0001209191-17-031120 · doc4.xml · nonDerivative · entry 2 Chiu Shin-Shing Bosco · CIK 0001504597 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,508 F2 · kind: The reporting person forfeited 492 shares of common stock underlying the SARS in payment of the exercise price and 1,695 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 5, 2017 of $69.40. Read SEC document |
| May 05, 2017 Filed May 10, 2017 00:39 UTC |
Chiu Shin-Shing BoscoPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 5,000 | $6.82 | $34,100.00 |
DisclosureSEC source: 0001209191-17-031120 · doc4.xml · nonDerivative · entry 1 Chiu Shin-Shing Bosco · CIK 0001504597 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2016. Read SEC document |
| May 05, 2017 Filed May 10, 2017 00:26 UTC |
Bermingham Richard PDirector
|
SaleCommon Stock | 12,000 | $67.00 | $804,000.00 |
DisclosureSEC source: 0001209191-17-031100 · doc4.xml · nonDerivative · entry 1 Bermingham Richard P · CIK 0001301747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,429 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2016. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 12:00 UTC |
ICAHN CARL C10% owner
HIGH RIVER LIMITED PARTNERSHIP10% owner
ICAHN PARTNERS LP10% owner
ICAHN PARTNERS MASTER FUND LP10% owner
|
PurchaseCommon Shares, par value $0.001 per share ("Shares") | 372,324 | $51.35 | $19,118,837.40 |
DisclosureSEC source: 0001140361-17-011690 · doc1.xml · nonDerivative · entry 1 ICAHN CARL C · CIK 0000921669 · 10% owner HIGH RIVER LIMITED PARTNERSHIP · CIK 0000928464 · 10% owner ICAHN PARTNERS LP · CIK 0001313666 · 10% owner ICAHN PARTNERS MASTER FUND LP · CIK 0001322827 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · please see all footnotes Disclosed balance after: 22,872,324 F1 · ownership.nature: High River Limited Partnership ("High River") directly beneficially owns 4,574,465 Shares, Icahn Partners LP ("Icahn Partners") directly beneficially owns 10,851,021 Shares, and Icahn Partners Master Fund LP ("Icahn Master") directly beneficially owns 7,446,838 Shares. F2 · ownership.nature: Barberry Corp. ("Barberry") is the sole member of Hopper Investments LLC ("Hopper"), which is the general partner of High River. Beckton Corp. ("Beckton") is the sole stockholder of Icahn Enterprises G.P. Inc. ("Icahn Enterprises GP"), which is the general partner of Icahn Enterprises Holdings L.P. ("Icahn Enterprises Holdings"). Icahn Enterprises Holdings is the sole member of IPH GP LLC ("IPH"), which is the general partner of Icahn Capital LP ("Icahn Capital"). Icahn Capital is the general partner of each of Icahn Onshore LP ("Icahn Onshore") and Icahn Offshore LP ("Icahn Offshore"). Icahn Onshore is the general partner of Icahn Partners. Icahn Offshore is the general partner of Icahn Master. F3 · ownership.nature: Each of Barberry and Beckton is 100 percent owned by Carl C. Icahn. As such, Mr. Icahn is in a position indirectly to determine the investment and voting decisions made by each of High River, Icahn Partners, and Icahn Master. Each of Hopper, Barberry and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which High River owns. Each of Hopper, Barberry and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. F4 · ownership.nature: Each of Icahn Onshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which Icahn Partners owns. Each of Icahn Onshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. F5 · ownership.nature: Each of Icahn Offshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which Icahn Master owns. Each of Icahn Offshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. Read SEC document |
| March 07, 2017 Filed Mar 8, 2017 23:42 UTC |
Walsh DesPresident
|
Exercise / conversionStock Appreciation Right · Derivative | 32,236 | $0.00 Strike: $20.13 | $0.00 |
DisclosureSEC source: 0001209191-17-019413 · doc4.xml · derivative · entry 4 Walsh Des · CIK 0001373040 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,236 shares Expires 2017-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2017 Filed Mar 8, 2017 23:42 UTC |
Walsh DesPresident
|
Tax withholdingCommon Stock | 10,383 | $53.10 | $551,337.30 |
DisclosureSEC source: 0001209191-17-019413 · doc4.xml · nonDerivative · entry 3 Walsh Des · CIK 0001373040 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,738 F1 · kind: The reporting person received 9,635 shares of common stock upon the net exercise of the 32,236 stock appreciation rights ("SARS"). The reporting person forfeited 12,218 shares of common stock underlying the SARS in payment of the exercise price and 10,383 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on March 7, 2017 of $53.10. Read SEC document |
| March 07, 2017 Filed Mar 8, 2017 23:42 UTC |
Walsh DesPresident
|
Disposition to issuerCommon Stock | 12,218 | $53.10 | $648,775.80 |
DisclosureSEC source: 0001209191-17-019413 · doc4.xml · nonDerivative · entry 2 Walsh Des · CIK 0001373040 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,121 Read SEC document |
| March 07, 2017 Filed Mar 8, 2017 23:42 UTC |
Walsh DesPresident
|
Exercise / conversionCommon Stock | 32,236 | $20.13 | $648,749.50 |
DisclosureSEC source: 0001209191-17-019413 · doc4.xml · nonDerivative · entry 1 Walsh Des · CIK 0001373040 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: Not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 23:33 UTC |
LEVY ROBERTEVP, WW Sales & Marketing
|
Exercise / conversionStock Appreciation Right · Derivative | 32,236 | $0.00 Strike: $20.13 | $0.00 |
DisclosureSEC source: 0001209191-17-019410 · doc4.xml · derivative · entry 4 LEVY ROBERT · CIK 0001311283 · EVP, WW Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,236 shares Expires 2017-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 23:33 UTC |
LEVY ROBERTEVP, WW Sales & Marketing
|
Tax withholdingCommon Stock | 8,109 | $54.70 | $443,562.30 |
DisclosureSEC source: 0001209191-17-019410 · doc4.xml · nonDerivative · entry 3 LEVY ROBERT · CIK 0001311283 · EVP, WW Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,747 F1 · kind: The reporting person received 12,266 shares of common stock upon the net exercise of the 32,236 stock appreciation rights ("SARS"). The reporting person forfeited 11,861 shares of common stock underlying the SARS in payment of the exercise price and 8,109 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on March 6, 2017 of $54.70. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 23:33 UTC |
LEVY ROBERTEVP, WW Sales & Marketing
|
Disposition to issuerCommon Stock | 11,861 | $54.70 | $648,796.70 |
DisclosureSEC source: 0001209191-17-019410 · doc4.xml · nonDerivative · entry 2 LEVY ROBERT · CIK 0001311283 · EVP, WW Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,856 Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 23:33 UTC |
LEVY ROBERTEVP, WW Sales & Marketing
|
Exercise / conversionCommon Stock | 32,236 | $20.13 | $648,749.50 |
DisclosureSEC source: 0001209191-17-019410 · doc4.xml · nonDerivative · entry 1 LEVY ROBERT · CIK 0001311283 · EVP, WW Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: Not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 00:16 UTC |
Dunn JeffDirector
|
Exercise / conversionStock Appreciation Rights · Derivative | 13,064 | $0.00 Strike: $22.94 | $0.00 |
DisclosureSEC source: 0001209191-17-018508 · doc4.xml · derivative · entry 3 Dunn Jeff · CIK 0001476192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,064 shares Expires 2017-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 00:16 UTC |
Dunn JeffDirector
|
Disposition to issuerCommon Stock | 5,353 | $55.99 | $299,714.47 |
DisclosureSEC source: 0001209191-17-018508 · doc4.xml · nonDerivative · entry 2 Dunn Jeff · CIK 0001476192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,589 F1 · kind: The reporting person received 7,711 shares of common stock upon the net exercise of the 13,064 stock appreciation rights ("SARS"). The reporting person forfeited 5,353 shares of common stock underlying the SARS in payment of the exercise price, using the closing stock price on March 3, 2017 of $55.99. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 00:16 UTC |
Dunn JeffDirector
|
Exercise / conversionCommon Stock | 13,064 | $22.94 | $299,688.16 |
DisclosureSEC source: 0001209191-17-018508 · doc4.xml · nonDerivative · entry 1 Dunn Jeff · CIK 0001476192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2017 Filed Mar 2, 2017 22:30 UTC |
Tartol JohnDirector
|
SaleCommon Stock | 2,758 | $56.48 | $155,771.84 |
DisclosureSEC source: 0001209191-17-016813 · doc4.xml · nonDerivative · entry 3 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,422 Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 22:31 UTC |
Cardoso PedroDirector
|
Exercise / conversionStock Appreciation Rights · Derivative | 13,064 | $0.00 Strike: $22.94 | $0.00 |
DisclosureSEC source: 0001209191-17-016815 · doc4.xml · derivative · entry 3 Cardoso Pedro · CIK 0001463406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,064 shares Expires 2017-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 22:31 UTC |
Cardoso PedroDirector
|
Disposition to issuerCommon Stock | 5,287 | $56.69 | $299,720.03 |
DisclosureSEC source: 0001209191-17-016815 · doc4.xml · nonDerivative · entry 2 Cardoso Pedro · CIK 0001463406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,206 F1 · kind: The reporting person received 7,777 shares of common stock upon the net exercise of the 13,064 stock appreciation rights ("SARS"). The reporting person forfeited 5,287 shares of common stock underlying the SARS in payment of the exercise price, using the closing stock price on March 1, 2017 of $56.69. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 22:31 UTC |
Cardoso PedroDirector
|
Exercise / conversionCommon Stock | 13,064 | $22.94 | $299,688.16 |
DisclosureSEC source: 0001209191-17-016815 · doc4.xml · nonDerivative · entry 1 Cardoso Pedro · CIK 0001463406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 22:31 UTC |
Li JerrySVP, Managing Director, China
|
SaleCommon Stock | 2,000 | $56.73 | $113,460.00 |
DisclosureSEC source: 0001209191-17-017793 · doc4.xml · nonDerivative · entry 1 Li Jerry · CIK 0001615439 · SVP, Managing Director, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:30 UTC |
JOHNSON MICHAELDirector · Chairman & CEO
|
Exercise / conversionStock Appreciation Right · Derivative | 290,000 | $0.00 Strike: $20.13 | $0.00 |
DisclosureSEC source: 0001209191-17-016030 · doc4.xml · derivative · entry 6 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 290,000 shares Expires 2017-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:30 UTC |
JOHNSON MICHAELDirector · Chairman & CEO
|
Tax withholdingCommon Stock | 100,667 | $56.49 | $5,686,678.83 |
DisclosureSEC source: 0001209191-17-016030 · doc4.xml · nonDerivative · entry 3 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,682,135 F1 · kind: The reporting person received 86,018 shares of common stock upon the net exercise of the 290,000 stock appreciation rights ("SARS"). The reporting person forfeited 103,315 shares of common stock underlying the SARS in payment of the exercise price and 100,667 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on February 28, 2017 of $56.49. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:30 UTC |
JOHNSON MICHAELDirector · Chairman & CEO
|
Disposition to issuerCommon Stock | 103,315 | $56.49 | $5,836,264.35 |
DisclosureSEC source: 0001209191-17-016030 · doc4.xml · nonDerivative · entry 2 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,782,802 Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:30 UTC |
JOHNSON MICHAELDirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 290,000 | $20.13 | $5,836,250.00 |
DisclosureSEC source: 0001209191-17-016030 · doc4.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,886,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 22:30 UTC |
Tartol JohnDirector
|
Exercise / conversionStock Appreciation Rights · Derivative | 13,064 | $0.00 Strike: $22.94 | $0.00 |
DisclosureSEC source: 0001209191-17-016813 · doc4.xml · derivative · entry 4 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,064 shares Expires 2017-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 22:30 UTC |
Tartol JohnDirector
|
Disposition to issuerCommon Stock | 5,306 | $56.49 | $299,735.94 |
DisclosureSEC source: 0001209191-17-016813 · doc4.xml · nonDerivative · entry 2 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,180 F1 · kind: The reporting person received 7,758 shares of common stock upon the net exercise of the 13,064 stock appreciation rights ("SARS"). The reporting person forfeited 5,306 shares of common stock underlying the SARS in payment of the exercise price, using the closing stock price on February 28, 2017 of $56.49 and sold 2,758 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 22:30 UTC |
Tartol JohnDirector
|
Exercise / conversionCommon Stock | 13,064 | $22.94 | $299,688.16 |
DisclosureSEC source: 0001209191-17-016813 · doc4.xml · nonDerivative · entry 1 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:22 UTC |
LEVY ROBERTEVP, WW Sales & Marketing
|
GrantStock Appreciation Rights · Derivative | 4,367 | $0.00 Strike: $62.51 | $0.00 |
DisclosureSEC source: 0001209191-17-015007 · doc4.xml · derivative · entry 3 LEVY ROBERT · CIK 0001311283 · EVP, WW Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,367 Underlying: Common Stock · 4,367 shares Expires 2026-05-09 F3 · balance_after: On May 9, 2016, the reporting person was granted an award of 21,834 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 4,367 SARs which will vest on May 9, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:22 UTC |
LEVY ROBERTEVP, WW Sales & Marketing
|
GrantStock Appreciation Rights · Derivative | 10,603 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001209191-17-015007 · doc4.xml · derivative · entry 2 LEVY ROBERT · CIK 0001311283 · EVP, WW Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,206 Underlying: Common Stock · 10,603 shares Expires 2025-03-02 F2 · balance_after: On March 2, 2015, the reporting person was granted an award of 53,017 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 10,603 SARs which will vest on March 2, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:22 UTC |
LEVY ROBERTEVP, WW Sales & Marketing
|
GrantStock Appreciation Rights · Derivative | 15,011 | $0.00 Strike: $59.98 | $0.00 |
DisclosureSEC source: 0001209191-17-015007 · doc4.xml · derivative · entry 1 LEVY ROBERT · CIK 0001311283 · EVP, WW Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,019 Underlying: Common Stock · 15,011 shares Expires 2024-04-30 F1 · balance_after: On April 30, 2014, the reporting person was granted an award of 25,019 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2014, 2015 and 2016. The performance criteria for 2016 was met, resulting in 15,011 SARs which will vest on April 30, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:25 UTC |
Walsh DesPresident
|
GrantStock Appreciation Rights · Derivative | 12,133 | $0.00 Strike: $62.51 | $0.00 |
DisclosureSEC source: 0001209191-17-015018 · doc4.xml · derivative · entry 4 Walsh Des · CIK 0001373040 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,133 Underlying: Common Stock · 12,133 shares Expires 2026-05-09 F4 · balance_after: On May 9, 2016, the reporting person was granted an award of 60,655 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 12,133 SARs which will vest on May 9, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:25 UTC |
Walsh DesPresident
|
GrantStock Appreciation Rights · Derivative | 16,650 | $0.00 Strike: $47.80 | $0.00 |
DisclosureSEC source: 0001209191-17-015018 · doc4.xml · derivative · entry 3 Walsh Des · CIK 0001373040 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,300 Underlying: Common Stock · 16,650 shares Expires 2025-05-07 F3 · balance_after: On May 7, 2015, the reporting person was granted an award of 83,250 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 16,650 SARs which will vest on May 7, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:25 UTC |
Walsh DesPresident
|
GrantStock Appreciation Rights · Derivative | 24,470 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001209191-17-015018 · doc4.xml · derivative · entry 2 Walsh Des · CIK 0001373040 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,940 Underlying: Common Stock · 24,470 shares Expires 2025-03-02 F2 · balance_after: On March 2, 2015, the reporting person was granted an award of 122,349 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 24,470 SARs which will vest on March 2, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.